Insider Transactions Reported by 15 Insiders of CG Oncology, Inc.

Symbol
CGON on Nasdaq
Location
Irvine, CA

Insiders trading volume in the past year

CG Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Hong Fang Song Director $196,765,813 -$2,779,542 -1.4% 03 Sep 2025
Decheng Capital Global Life Sciences Fund IV, L.P. 10%+ Owner $175,343,522 29 Jan 2024
Brian Guan-Chyun Liu Director $49,999,983 +$49,999,983 11 Sep 2025
Arthur Kuan Chief Executive Officer, Director $7,290,886 04 Mar 2026
James Mulay Director $0 -$3,081,047 -100% 09 Jan 2026
LEONARD E. POST Director $0 -$490,990 -100% 17 Nov 2025
Bob Lapetina Interim Principal Financial and Accounting Officer 05 Aug 2025
Christina Rossi Director 24 Nov 2025
Corleen Roche Cfo 15 Apr 2025
JAMES M. DETORE Interim Principal Financial and Accounting Officer 17 Nov 2025
Ambaw Bellete President and COO 15 Apr 2025
Victor Edward Tong Jr Director 05 Jun 2025
Susan E. Graf Director 05 Jun 2025
Vijay Kasturi Chief Medical Officer 15 Apr 2025
Joshua F. Patterson General Counsel and Chief Compliance Officer 15 Apr 2025

Recent Insider Transactions by Companies or Individuals for CG Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.